alzamend neuro regains compliance with nasdaq listing standards
ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of...
Month: October 2024
24/7 Market News Snapshot 15 October, 2024 – Immuneering Corporation Class A Common Stock (NASDAQ:IMRX)
DENVER, Colo., 15 October, 2024 (247marketnews.com) – (NASDAQ:IMRX) are discussed in this article. Immuneering Corporation is experiencing notable momentum in...
akebia therapeutics announces seven poster presentations at asn kidney week 2024
Vadadustat clinical data on display for nephrologist and healthcare providers in advance of U.S. market availability expected in January 2025...
graham corporation launches nextgen steam ejector nozzle with successful gulf coast refinery installation, delivering significant energy savings and emissions reductions
BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM) (“Graham” or “the Company”), a global leader in the design and manufacture of mission...
palamina participating in two separate drilling campaigns in the puno orogenic gold belt
Toronto, Ontario--(Newsfile Corp. - October 15, 2024) - Palamina Corp. (TSXV: PA) (OTCQB: PLMNF) is drilling at its Usicayos Gold...
akari therapeutics announces effectiveness of form s-4 and general meeting date of november 7, 2024 related to peak bio merger
BOSTON and LONDON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced...
pineapple energy announces previously approved reverse stock split, effective october 17, 2024
RONKONKOMA, N.Y., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Pineapple Energy Inc. (the “Company”) (NASDAQ: PEGY) announced today that effective at...
enveric biosciences announces positive pharmacology and safety data for lead product, eb-003
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic...
omega therapeutics to present multiple posters highlighting versatile platform capabilities at upcoming scientific meetings
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the...
24/7 Market News Snapshot 15 October, 2024 – Enveric Biosciences, Inc. Common Stock (NASDAQ:ENVB)
DENVER, Colo., 15 October, 2024 (247marketnews.com) – (NASDAQ:ENVB) are discussed in this article. Enveric Biosciences, Inc. (ENVB) has garnered considerable...
easterly government properties acquires 104,136 sf facility adjacent to buckley space force base and occupied by northrop grumman systems corporation
WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily...
zyversa therapeutics ceo, stephen c. glover, was a featured guest on the big biz show to discuss current trends in the obesity drug market and the potential role of inflammasome inhibitors
WESTON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical...
nkgen biotech announces upcoming presentation at the 16th world stroke congress (wsc 2024)
SANTA ANA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage...
xtreme one entertainment lets retail investors get into the fight game with a $10 million common stock offering to accelerate its xfc 3-year growth plan
DETROIT, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Xtreme One Entertainment, Inc. (OTC Pink: XONI) (the “Company” or “Xtreme One”), parent...
nabors industries announces agreement to acquire parker wellbore
HAMILTON, Bermuda, Oct. 15, 2024 /PRNewswire/ -- Nabors Industries Ltd. ("Nabors") (NYSE: NBR) and Parker Wellbore ("Parker") today announced a definitive...
cervomed announces last patient last visit in phase 2b rewind-lb trial of neflamapimod for the treatment of early-stage dementia with lewy bodies (dlb)
• On track to report topline data from the Phase 2b trial in December 2024 • Neflamapimod has the potential to...
western digital delivers world’s highest capacity epmr hdds to meet growing nearline demand
SAN JOSE, Calif.--(BUSINESS WIRE)--More than just storage, Western Digital HDDs are key enablers for businesses looking to optimize their infrastructure,...
ventyx biosciences presents new 52-week results from the phase 2 trial of vtx002 (tamuzimod) in ulcerative colitis at ueg week 2024
SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on...
millennial potash provides update on recent cooperation agreements between the united states and gabon
West Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Millennial Potash Corp. (TSXV: MLP) (OTCQB: MLPNF) (FSE: X0D) ("MLP",...
nine mile metals tdem survey at california lake south identifies massive target with 4 high priority plates and mobilizes drill rig
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - NINE MILE METALS LTD. (CSE: NINE) (OTCQB: VMSXF) (FSE: KQ9) (the...
lucid diagnostics receives notice of allowance for key patent underlying its esoguard esophageal dna test
Patent covers proprietary method using methylation of the CCNA1 gene to help detect esophageal precancer and cancer NEW YORK, Oct....
twist bioscience appoints mike fero, ph.d., as chief information officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality...
one world products secures first order for hemp-based reusable containers, pioneers renewable materials for the automotive industry
LAS VEGAS, Nev., Oct. 15, 2024 (GLOBE NEWSWIRE) -- One World Products, Inc. (the “Company”) (OTCQB: OWPC), a Nevada-based leader...
ocular therapeutix™ announces accelerated timelines for sol-1 registrational trial of axpaxli™ in wet amd
SOL-1 is now expected to be enrolled and fully randomized by year-end 2024 Topline clinical data from SOL-1 are now...
zenatech announces first us trial of the zenadrone iq nano drone for inventory management by an auto parts manufacturer
TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence)...
jazz pharmaceuticals announces statistically significant overall survival and progression-free survival results for zepzelca® (lurbinectedin) and atezolizumab combination in first-line maintenance therapy for extensive-stage small cell lung cancer
Jazz plans to submit supplemental New Drug Application in first half of 2025 for this combination therapy as a first-line...
sierra metals reports third quarter 2024 production results and expects to exceed 2024 consolidated production guidance
TORONTO--(BUSINESS WIRE)--Sierra Metals Inc. (TSX: SMT; OTC: SMTSF; BVL: SMT) (“Sierra Metals” or the “Company”) reports third quarter 2024 production...
rail vision to participate at the ld micro main event xvii
Presentation on Wednesday, October 30th at 10:30 PM PT Ra’anana, Israel, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd....
cartesian therapeutics announces presentation of results from phase 2b trial of descartes-08 in patients with myasthenia gravis at the 2024 mgfa scientific session of the aanem annual meeting
GAITHERSBURG, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering...
whitehorse finance, inc. announces special distribution and to report third quarter 2024 financial results
NEW YORK, Oct. 15, 2024 /PRNewswire/ -- WhiteHorse Finance, Inc. (the "Company") (Nasdaq: WHF) today announced that its board of directors...
mrc global announces actions to strengthen its capital structure
Agrees to Repurchase Preferred StockLaunches Term Loan B Financing to Fund RepurchasePursues Amendment to ABL Facility to Extend MaturityProvides Preliminary...
state street cfo to depart for new position following transition period
BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) today announced that Eric Aboaf, vice chairman and chief financial officer (CFO), has made...
axsome therapeutics to report third quarter 2024 financial results on november 12
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
ivanhoe electric’s vrb energy subsidiary and red sun sign definitive agreements for formation of new grid scale battery joint venture
Ivanhoe Electric to Allocate $20 million of Transaction Proceeds to Establish US-Domiciled Vanadium Redox Flow Battery BusinessPhoenix, Arizona--(Newsfile Corp. -...
sun summit minerals appoints terry salman as strategic advisor
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Sun Summit Minerals Corp. (TSXV: SMN) (OTCQB: SMREF) is pleased to...
gogo galileo tour launches nationwide
State-of-the-Art Mobile Demo Room Coming to a City Near You BROOMFIELD, Colo., Oct. 15, 2024 /PRNewswire/ -- Gogo Business Aviation...
aero energy highlights discovery potential on the high-grade murmac and sun dog uranium projects
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Aero Energy Limited (TSXV: AERO) (OTC Pink: AAUGF) (FSE: UU3) ("Aero"...
gain therapeutics announces poster presentation at 36th eortc-nci-aacr symposium on molecular targets and cancer therapeutics
BETHESDA, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
encore energy continues to encounter high grade drill results from the alta mesa uranium project
NASDAQ:EUTSXV:EUwww.encoreuranium.com DALLAS, Oct. 15, 2024 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), a United States uranium producer,...
lancet rheumatology publishes phase 2b data on eupraxia pharmaceuticals’ ep-104iar for the treatment of knee osteoarthritis
Publication of Eupraxia's Phase 2b data in Lancet Rheumatology, a distinguished and respected journal, raises the profile of EP-104IAR. As outlined...